{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:10:06Z","timestamp":1770883806995,"version":"3.50.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"DOI":"10.1093\/toxsci\/kfu162","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T08:41:43Z","timestamp":1408092103000},"page":"196-209","source":"Crossref","is-referenced-by-count":56,"title":["SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients"],"prefix":"10.1093","volume":"142","author":[{"given":"Aurea","family":"Lima","sequence":"first","affiliation":[]},{"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"Joaquim","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]},{"given":"V\u00edtor","family":"Seabra","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"key\n\t\t\t\t20171012035220_B1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"key\n\t\t\t\t20171012035220_B2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/rheumatology\/ken073","article-title":"Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells","volume":"47","author":"Baslund","year":"2008","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20171012035220_B3","doi-asserted-by":"crossref","first-page":"845496","DOI":"10.1155\/2011\/845496","article-title":"Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literature","volume":"2011","author":"Benucci","year":"2011","journal-title":"Int. J. Rheumatol."},{"key":"key\n\t\t\t\t20171012035220_B4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp0600687","article-title":"Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine","volume":"4","author":"Berggren","year":"2007","journal-title":"Mol. Pharm."},{"key":"key\n\t\t\t\t20171012035220_B5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6)","volume":"314","author":"Bleasby","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20171012035220_B6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2217\/pgs.12.150","article-title":"Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients","volume":"13","author":"Bohanec Grabar","year":"2012","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20171012035220_B7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00228-008-0521-7","article-title":"Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: A study of polymorphisms affecting methotrexate transport and folate metabolism","volume":"64","author":"Bohanec Grabar","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20171012035220_B8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-61779-228-1_11","article-title":"Genotyping with Sequenom","volume":"772","author":"Bradic","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20171012035220_B9","first-page":"203","article-title":"Epidemiological study of rheumatic diseases in Portugal\u2014EpiReumaPt","volume":"36","author":"Branco","year":"2011","journal-title":"Acta Reumatol. Port."},{"key":"key\n\t\t\t\t20171012035220_B10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00296-007-0339-0","article-title":"Transcription regulatory polymorphism -43T>C in the 5\u2019-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy","volume":"27","author":"Chatzikyriakidou","year":"2007","journal-title":"Rheumatol. Int."},{"key":"key\n\t\t\t\t20171012035220_B11","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3899\/jrheum.111593","article-title":"ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis","volume":"39","author":"de Rotte","year":"2012","journal-title":"J. Rheumatol."},{"key":"key\n\t\t\t\t20171012035220_B12","first-page":"16","article-title":"Terap\u00eautica anti-inflamat\u00f3ria em reumatologia: Coxibes. Parte I: b. Epidemiologia da osteoartrose e da artrite reumat\u00f3ide","volume":"10","author":"Dias","year":"2001","journal-title":"Anamnesis"},{"issue":"Suppl. 13","key":"key\n\t\t\t\t20171012035220_B13","first-page":"S295","article-title":"Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis","volume":"18","author":"Gibofsky","year":"2012","journal-title":"Am. J. Manag. Care"},{"key":"key\n\t\t\t\t20171012035220_B14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.clpt.6100056","article-title":"Intestinal drug transporter expression and the impact of grapefruit juice in humans","volume":"81","author":"Glaeser","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"key\n\t\t\t\t20171012035220_B15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family\u2014structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"key\n\t\t\t\t20171012035220_B16","doi-asserted-by":"crossref","first-page":"978396","DOI":"10.1155\/2012\/978396","article-title":"Markers of treatment response to methotrexate in rheumatoid arthritis: Where do we stand","volume":"2012","author":"Halilova","year":"2012","journal-title":"Int. J. Rheumatol."},{"key":"key\n\t\t\t\t20171012035220_B17","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.4081\/ejh.2011.e3","article-title":"Subcellular localization and distribution of the reduced folate carrier in normal rat tissues","volume":"5","author":"Hinken","year":"2011","journal-title":"Eur. J. Histochem."},{"key":"key\n\t\t\t\t20171012035220_B18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/7687","article-title":"Loss of information due to ambiguous haplotyping of SNPs","volume":"21","author":"Hodge","year":"1999","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20171012035220_B19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2133\/dmpk.DMPK-13-RV-119","article-title":"Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy","volume":"29","author":"Inoue","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"key\n\t\t\t\t20171012035220_B20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20171012035220_B21","doi-asserted-by":"crossref","first-page":"G156","DOI":"10.1152\/ajpgi.2000.278.1.G156","article-title":"A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane","volume":"278","author":"Konig","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"key\n\t\t\t\t20171012035220_B22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2217\/pgs.09.139","article-title":"Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis","volume":"11","author":"Kooloos","year":"2010","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20171012035220_B23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/art.20278","article-title":"Toward a better understanding of methotrexate","volume":"50","author":"Kremer","year":"2004","journal-title":"Arthritis Rheum."},{"key":"key\n\t\t\t\t20171012035220_B24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2217\/pgs.13.118","article-title":"Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics","volume":"14","author":"Lima","year":"2013","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20171012035220_B25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2217\/pgs.13.244","article-title":"SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients","volume":"15","author":"Lima","year":"2013","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20171012035220_B26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/molbev\/msi100","article-title":"The evolution of transcription-initiation sites","volume":"22","author":"Lynch","year":"2005","journal-title":"Mol. Biol. Evol."},{"key":"key\n\t\t\t\t20171012035220_B27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/FPC.0b013e328343dd93","article-title":"PharmGKB summary: Methotrexate pathway","volume":"21","author":"Mikkelsen","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"key\n\t\t\t\t20171012035220_B28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FPC.0b013e32833f2cd0","article-title":"Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: Correlation between gene expression and genotype","volume":"20","author":"Moncrieffe","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"key\n\t\t\t\t20171012035220_B29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.berh.2004.08.008","article-title":"How to predict prognosis in early rheumatoid arthritis","volume":"19","author":"Morel","year":"2005","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"key\n\t\t\t\t20171012035220_B30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/bdra.20706","article-title":"Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele","volume":"88","author":"O'Byrne","year":"2010","journal-title":"Birth Defects Res. A. Clin. Mol. Teratol."},{"key":"key\n\t\t\t\t20171012035220_B31","first-page":"CD000951","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"2","author":"Ortiz","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"key\n\t\t\t\t20171012035220_B32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/tpj.2012.7","article-title":"Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients","volume":"13","author":"Owen","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"key\n\t\t\t\t20171012035220_B33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/tpj.2012.7","article-title":"Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients","volume":"13","author":"Owen","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"key\n\t\t\t\t20171012035220_B34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/omi.2011.0142","article-title":"Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis","volume":"16","author":"Plaza-Plaza","year":"2012","journal-title":"OMICS"},{"key":"key\n\t\t\t\t20171012035220_B35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"key\n\t\t\t\t20171012035220_B36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cell.2006.09.041","article-title":"Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption","volume":"127","author":"Qiu","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171012035220_B37","first-page":"572","article-title":"Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis","volume":"35","author":"Ranganathan","year":"2008","journal-title":"J. Rheumatol."},{"key":"key\n\t\t\t\t20171012035220_B38","first-page":"1037","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"72","author":"Rindfleisch","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"key\n\t\t\t\t20171012035220_B39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/338688","article-title":"Score tests for association between traits and haplotypes when linkage phase is ambiguous","volume":"70","author":"Schaid","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"Suppl. 3","key":"key\n\t\t\t\t20171012035220_B40","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res."},{"key":"key\n\t\t\t\t20171012035220_B41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/tpj.2012.37","article-title":"Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy","volume":"13","author":"Simon","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"key\n\t\t\t\t20171012035220_B42","first-page":"E427","article-title":"Painful rheumatoid arthritis","volume":"14","author":"Smith","year":"2011","journal-title":"Pain Physician"},{"key":"key\n\t\t\t\t20171012035220_B43","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: A web tool for the analysis of association studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20171012035220_B44","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1074\/jbc.270.14.7842","article-title":"Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells","volume":"270","author":"Spinella","year":"1995","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20171012035220_B45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/FPC.0b013e3283398a71","article-title":"Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate","volume":"20","author":"Stamp","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"key\n\t\t\t\t20171012035220_B46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/bbrc.2001.4774","article-title":"Isolation of a family of organic anion transporters from human liver and kidney","volume":"283","author":"Sun","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20171012035220_B47","first-page":"473","article-title":"Methotrexate in rheumatoid arthritis","volume":"58","author":"Swierkot","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"key\n\t\t\t\t20171012035220_B48","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: Implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian","year":"2007","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"key\n\t\t\t\t20171012035220_B49","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1200\/JCO.2008.20.4156","article-title":"Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects","volume":"27","author":"Trevino","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20171012035220_B50","article-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03","author":"U.S. Department of Health and Human Services","year":"2010"},{"key":"key\n\t\t\t\t20171012035220_B51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2006.02655.x","article-title":"Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters","volume":"62","author":"Vormfelde","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20171012035220_B52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.fpc.0000178311.02878.83","article-title":"Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability","volume":"15","author":"Wang","year":"2005","journal-title":"Pharmacogenetics Genomics"},{"key":"key\n\t\t\t\t20171012035220_B53","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrg2164","article-title":"Splicing in disease: Disruption of the splicing code and the decoding machinery","volume":"8","author":"Wang","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"key\n\t\t\t\t20171012035220_B54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/aje\/kws330","article-title":"Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: The PAGE Study","volume":"177","author":"Zhang","year":"2013","journal-title":"Am. J. Epidemiol."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/142\/1\/196\/10916755\/kfu162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:24:23Z","timestamp":1565742263000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/toxsci\/article\/142\/1\/196\/1707453\/SLC19A1-SLC46A1-and-SLCO1B1-Polymorphisms-as"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,8,14]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfu162","relation":{},"ISSN":["1096-0929","1096-6080"],"issn-type":[{"value":"1096-0929","type":"electronic"},{"value":"1096-6080","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,8,14]]}}}